Amryt Pharma Plc
(NASDAQ) AMYT
Amryt Pharma Plc Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$243.62M
Net Income (TTM)
$19.96M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AMYT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amryt Pharma Plc
Industry
Pharmaceuticals
Sector
Health CareCEO
Joe Wiley, PhD, MBA
Website
www.amrytpharma.comHeadquarters
Dublin, 4, IE
AMYT Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
-10%
Net Income Margin
-8%
Return on Equity
-9%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$116.42M
Operating Income
$21.64M
EBITDA
$76.75M
Operating Cash Flow
$15.53M
Capital Expenditure
$1.54M
Free Cash Flow
$13.99M
Cash & ST Invst.
$112.77M
Total Debt
$199.18M
Amryt Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$61.13M
+8.2%
Gross Profit
$27.42M
-6.3%
Gross Margin
44.86%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
289
N/A
Net Income
$20.80M
-20.8%
EBITDA
$5.23M
+177.8%
Quarterly Fundamentals
Net Cash
$129.54M
-64.0%
Accounts Receivable
$50.81M
-3.8%
Inventory
$90.24M
-10.5%
Long Term Debt
$211.82M
+5.6%
Short Term Debt
$966.00K
-36.8%
Return on Assets
-2.32%
N/A
Return on Invested Capital
-3.46%
N/A
Free Cash Flow
$14.00M
+111.3%
Operating Cash Flow
$14.34M
+111.5%